Martin K Rutter

Summary

Affiliation: Manchester Royal Infirmary
Country: UK

Publications

  1. ncbi request reprint The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes
    Martin K Rutter
    Diabetes and General Internal Medicine, Manchester Royal Infirmary, Manchester, UK
    Nat Clin Pract Endocrinol Metab 3:26-35. 2007
  2. pmc Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes
    Martin K Rutter
    University of Manchester, Manchester, UK
    Diabetes Care 35:1944-50. 2012
  3. doi request reprint Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care
    Martin K Rutter
    Cardiovascular Research Group, Core Technology Facility, School of Biomedicine, University of Manchester, 46 Grafton Street, Manchester, UK
    Eur Heart J 32:2247-55. 2011
  4. pmc Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease
    Martin K Rutter
    Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, and The Manchester Diabetes Centre, Manchester Royal Infirmary, Manchester, United Kingdom
    Circulation 117:1003-9. 2008
  5. ncbi request reprint Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes
    Martin K Rutter
    Department of Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
    J Am Coll Cardiol 40:56-61. 2002
  6. ncbi request reprint Enhanced External Counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes
    Georgiann Linnemeier
    HeartGen Center, Indianapolis, Ind, USA
    Am Heart J 146:453-8. 2003
  7. ncbi request reprint C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study
    Martin K Rutter
    Countess of Chester Hospital, Chester, UK
    Circulation 110:380-5. 2004
  8. ncbi request reprint Ischemia imaging and plaque imaging in diabetes: Complementary tools to improve cardiovascular risk management: Response to Raggi et al
    Martin K Rutter
    Diabetes Care 29:1187; author reply 1188. 2006
  9. ncbi request reprint Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome
    James B Meigs
    Harvard Medical School and the General Medicine Division, Massachusetts General Hospital, 50 Staniford St, 9th Floor, Boston, MA 02114, USA
    Diabetes Care 30:1219-25. 2007

Collaborators

Detail Information

Publications9

  1. ncbi request reprint The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes
    Martin K Rutter
    Diabetes and General Internal Medicine, Manchester Royal Infirmary, Manchester, UK
    Nat Clin Pract Endocrinol Metab 3:26-35. 2007
    ..Carefully conducted clinical trails using state-of-the-art investigations and therapy in well-characterized patients with diabetes are urgently required to inform physicians on when and how to intervene...
  2. pmc Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes
    Martin K Rutter
    University of Manchester, Manchester, UK
    Diabetes Care 35:1944-50. 2012
    ..Our objective was to assess whether impaired fasting glucose (IFG) and obesity are independently related to coronary artery calcification (CAC) in a community-based population...
  3. doi request reprint Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care
    Martin K Rutter
    Cardiovascular Research Group, Core Technology Facility, School of Biomedicine, University of Manchester, 46 Grafton Street, Manchester, UK
    Eur Heart J 32:2247-55. 2011
    ....
  4. pmc Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease
    Martin K Rutter
    Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, and The Manchester Diabetes Centre, Manchester Royal Infirmary, Manchester, United Kingdom
    Circulation 117:1003-9. 2008
    ....
  5. ncbi request reprint Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes
    Martin K Rutter
    Department of Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
    J Am Coll Cardiol 40:56-61. 2002
    ....
  6. ncbi request reprint Enhanced External Counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes
    Georgiann Linnemeier
    HeartGen Center, Indianapolis, Ind, USA
    Am Heart J 146:453-8. 2003
    ..Enhanced external counterpulsation has recently emerged as a treatment option for select patients with chronic stable angina...
  7. ncbi request reprint C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study
    Martin K Rutter
    Countess of Chester Hospital, Chester, UK
    Circulation 110:380-5. 2004
    ..Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited...
  8. ncbi request reprint Ischemia imaging and plaque imaging in diabetes: Complementary tools to improve cardiovascular risk management: Response to Raggi et al
    Martin K Rutter
    Diabetes Care 29:1187; author reply 1188. 2006
  9. ncbi request reprint Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome
    James B Meigs
    Harvard Medical School and the General Medicine Division, Massachusetts General Hospital, 50 Staniford St, 9th Floor, Boston, MA 02114, USA
    Diabetes Care 30:1219-25. 2007
    ..Metabolic syndrome increases the risk for type 2 diabetes and cardiovascular disease (CVD) and may be associated with insulin resistance...